Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 113

1.

CXCR4 expression in bladder transitional cell carcinoma and its relationship with clinicopathological features.

Li Y, Chen M, Yuan J, Zhou X, He W, Zu X, Qi L.

Urol Int. 2014;92(2):157-63. doi: 10.1159/000351952. Epub 2013 Aug 27.

PMID:
23988662
2.

Down-regulated microRNA-101 in bladder transitional cell carcinoma is associated with poor prognosis.

Zhang H, Qi F, Cao Y, Chen M, Zu X.

Med Sci Monit. 2014 May 17;20:812-7. doi: 10.12659/MSM.890300.

4.

[DAB2IP expression in bladder transitional cell carcinoma and its correlation with clinical outcome].

Zhu JN, Wu KJ, Guan ZF, Liu LX, Ning ZY, Zhou JC, Wang XY, Fan JH.

Sichuan Da Xue Xue Bao Yi Xue Ban. 2014 Jul;45(4):591-4. Chinese.

PMID:
25286682
5.
6.

[Smad4 and TGF-beta1 expression and clinical significance in bladder transitional cell carcinoma].

Tang ZY, Yang LY, Zhang YJ, Peng KL, Qi L.

Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2006 Jun;31(3):363-6. Chinese.

7.

Intratumoral lymphatics and lymphatic vessel invasion detected by D2-40 are essential for lymph node metastasis in bladder transitional cell carcinoma.

Ma Y, Hou Y, Liu B, Li X, Yang S, Ma J.

Anat Rec (Hoboken). 2010 Nov;293(11):1847-54. doi: 10.1002/ar.21217.

8.

[The clinico-pathological significance of protein expression of PAK1 in bladder transitional cell carcinoma].

Zhang YH, Xie D, Luo JH, Chen W, Chen LW, Xu QC, Liu GY, Ma HB, Lin WQ.

Zhonghua Yi Xue Za Zhi. 2007 Oct 16;87(38):2710-3. Chinese.

PMID:
18167251
9.

Vascular endothelial growth factor-C associated with computed tomography used in the diagnosis of lymph node metastasis of bladder carcinoma.

Li Z, Qi F, Miao J, Zu X, He W, Wang L, Qi L.

Arch Med Res. 2010 Nov;41(8):606-10. doi: 10.1016/j.arcmed.2010.11.003.

PMID:
21199729
10.

Expression of hedgehog pathway components is associated with bladder cancer progression and clinical outcome.

He HC, Chen JH, Chen XB, Qin GQ, Cai C, Liang YX, Han ZD, Dai QS, Chen YR, Zeng GH, Zhu JG, Jiang FN, Zhong WD.

Pathol Oncol Res. 2012 Apr;18(2):349-55. doi: 10.1007/s12253-011-9451-2. Epub 2011 Aug 24.

PMID:
21861243
11.

Expression of brain‑specific angiogenesis inhibitor‑1 and association with p53, microvessel density and vascular endothelial growth factor in the tissue of human bladder transitional cell carcinoma.

Tian D, Hu H, Sun Y, Tang Y, Lei M, Liu L, Han R, Wu C.

Mol Med Rep. 2015 Sep;12(3):4522-9. doi: 10.3892/mmr.2015.3984. Epub 2015 Jun 23.

PMID:
26129954
12.

[New markers for pharmacological targeting in bladder cancer with lymph node metastasis].

Herrmann E, Eltze E, Köpke T, Bolenz C, Bierer S, Neumann J, Hertle L, Wülfing C.

Aktuelle Urol. 2007 Sep;38(5):392-7. German.

PMID:
17907066
13.

Association of CXCR4 and CCR7 chemokine receptor expression and lymph node metastasis in human cervical cancer.

Kodama J, Hasengaowa, Kusumoto T, Seki N, Matsuo T, Ojima Y, Nakamura K, Hongo A, Hiramatsu Y.

Ann Oncol. 2007 Jan;18(1):70-6. Epub 2006 Oct 10.

14.

Correlation of tumor relapse and elevated expression of survivin and vascular endothelial growth factor in superficial bladder transitional cell carcinoma.

Sun YW, Xuan Q, Shu QA, Wu SS, Chen H, Xiao J, Xiang P, Zhu YP, Wang FL, Zhao ST.

Genet Mol Res. 2013 Apr 2;12(2):1045-53. doi: 10.4238/2013.April.2.21.

15.

Association of tumor-associated trypsin inhibitor (TATI) expression with molecular markers, pathologic features and clinical outcomes of urothelial carcinoma of the urinary bladder.

Patschan O, Shariat SF, Chade DC, Karakiewicz PI, Ashfaq R, Lotan Y, Hotakainen K, Stenman UH, Bjartell A.

World J Urol. 2012 Dec;30(6):785-94. doi: 10.1007/s00345-011-0727-7. Epub 2011 Jul 8.

PMID:
21739120
16.

[Expression of Her2/neu in locally advanced bladder cancer: implication for a molecular targeted therapy].

Wülfing C, von Struensee D, Bierer S, Bögemann M, Hertle L, Eltze E.

Aktuelle Urol. 2005 Sep;36(5):423-9. German.

PMID:
16163605
17.

Relationship between the expression of RASSF1A protein and promoter hypermethylation of RASSF1A gene in bladder tumor.

Hu J, Li H, Shi T, Ma X, Wang B, Xu H, Ai X, Ju Z, Wang C, Zhang G, Zhang X.

J Huazhong Univ Sci Technolog Med Sci. 2008 Apr;28(2):182-4. doi: 10.1007/s11596-008-0217-3. Epub 2008 May 15.

PMID:
18480993
18.

[Expression of Caspase-3 and Bcl-2 in bladder transitional carcinoma and their significance].

Shen HW, Yi L, Wang XM, Yao MJ, Deng JW, Fang JZ, Li MN.

Ai Zheng. 2004 Feb;23(2):181-4. Chinese.

PMID:
14960240
19.

Expression and predictive value of lymph-specific markers in urothelial carcinoma of the bladder.

von Hardenberg J, Martini T, Knauer A, Ströbel P, Becker A, Herrmann E, Schubert C, Steidler A, Bolenz C.

Urol Oncol. 2014 Jan;32(1):54.e9-17. doi: 10.1016/j.urolonc.2013.08.031.

PMID:
24360666
20.

Expression and prognostic significance of survivin in the progression of bladder transitional cell cancer.

Wang Y, Zhu Z, Zeng F, Wang L, Wu Y, Xia W, Xing S.

J Huazhong Univ Sci Technolog Med Sci. 2007 Aug;27(4):444-7.

PMID:
17828507
Items per page

Supplemental Content

Write to the Help Desk